Mapping loss of heterozygosity at chromosome 13q: Loss at 13q12-q13 is associated with breast turnout progression and poor prognosis

European Journal of Cancer

Volumn 34, Issue 13, 1998, Pages 2076-2081

  Eiriksdottir, G ^b   Johannesdottir, G ^b   Ingvarsson, S ^b   Bjornsdottir I B ^a   Jonasson, J G ^b   Agnarsson, B A ^b   Hallgrimsson, J ^b   Gudmundsson, J ^b   Egilsson, V ^b   Sigurdsson, H ^a   Barkardottir, R B ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b NONE

Author keywords

BRCA2; Breast cancer; Chromosome 13q; Deletion mapping; Prognosis; RB1

Indexed keywords

BRCA2 PROTEIN; PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST TUMOR; CANCER RECURRENCE; CELL CYCLE S PHASE; CHROMOSOME 13Q; CHROMOSOME MAP; FEMALE; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANEUPLOIDY; BRCA2 PROTEIN; BREAST NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; DISEASE-FREE SURVIVAL; FEMALE; GENE DELETION; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASM PROTEINS; PROGNOSIS; RECEPTORS, PROGESTERONE; S PHASE; TRANSCRIPTION FACTORS;

EID: 0032403676     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00241-X     Document Type: Article

References (40)

1. 1. Nowell PC. Mechanisms of tumor progression. Cancer Res 1986, 46, 2203-2207.
2. 2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61, 759-767.
3. 3. Devilee P, Cornelisse CJ. Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1994, 1198, 113-130.
4. 4. Bieche I, Lidereau R. Genetic alterations in breast cancer. Genes Chromosomes Cancer 1995, 14, 227-251.
5. 5. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235, 177-182.
6. 6. Bergh J, Norberg T, Sjögren S, Lindgren A, Holmberg L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nature Med 1995, 1, 1029-1034.
7. 7. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prage D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 1995, 55, 1613-1616.
8. 8. Zhang X, Xu HJ, Murakami Y, et al. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 1994, 54, 4177-4182.
9. 9. Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 1996, 56, 1142-1145.
10. 10. Schutte M, Da Costa LT, Hahn SA, et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci 1995, 92, 5950-5954.
11. 11. Liu Y, Heyman M, Wang Y, et al. Molecular analysis of the retinoblastoma gene in primary ovarian cancer cells. Int J Cancer 1994, 58, 663-667.
12. 12. Cleton-Jansen AM, Collins N, Lakhani SR, et al. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer 1995, 72, 1241-1244.
13. 13. Lundberg C, Skoog L, Cavenee WK, Nordenskjold M. Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13. Proc Natl Acad Sci USA 1987, 84, 2372-2376.
14. 14. Andersen TI, Gaustad A, Ottestad L, et al. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer 1992, 4, 113-121.
15. 15. Kerangueven F, Allione F, Noguchi T, et al. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors. Genes Chromosomes Cancer 1995, 13, 291-294.
16. 16. Beckmann MW, Picard F, An HX, et al. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer 1996, 73, 1220-1226.
17. 17. Hamman U, Herbold C, Costa S, et al. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. Cancer Res 1996, 56, 1988-1990.
18. 18. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lond.) 1986, 323, 643-646.
19. 19. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994, 265, 2088-2090.
20. 20. Tamura G, Maesawa C, Suzuki Y, et al. Improved detection of loss of heterozygosity at retinoblastoma gene locus in human breast carcinoma. Path Int 1994, 44, 4-38.
21. 21. Tsukamoto K, Ito N, Yoshimoto M, et al. Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas. Cancer 1996, 78, 1929-1934.
22. 22. Borg Å., Zhang Q, Alm P, Olsson H, Sellberg G. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 1992, 52, 2991-2994.
23. 23. van den Berg J, Johannsson O, Håkanson S, Olsson H, Borg Å. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br J Cancer 1996, 74, 1615-1619.
24. 24. Miki Y, Katagiri T, Kasumi F, Yoshimoto T, Nakamura Y. Mutation analysis in the BRCA2 gene in primary breast cancers. Nature Genet 1996, 13, 245-247.
25. 25. Gudmundsson J, Johannesdottir G, Arason A, et al. Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am J Hum Genet 1996, 58, 749-756.
26. 26. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nature Genet 1996, 13, 117-119.
27. 27. Johannesdottir G, Gudmundsson J, Bergthorsson JT, et al. High prevalence of the 999de15 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 1996, 56, 3663-3665.
28. 28. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16, 1215.
29. 29. Toguchida J, McGee TL, Paterson JC, et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 1993, 17, 535-543.
30. 30. Gyapay G, Morissette J, Vignal A, et al. The 1993-94 Généthon human genetic linkage map. Nature Genet 1994, 7, 246-339.
31. 31. Couch FJ, Rommens JM, Neuhausen SL, et al. Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics 1996, 36, 86-99.
32. 32. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378, 789-792.
33. 33. Vignal A, Gyapay G, Hazan J, et al. Nonradioactive multiplex procedure for genotyping of microsatellite markers. In Adolph KW, ed. Methods of Molecular Genetics, Vol. 1. San Diego, Academic Press, 1993, 211-221.
34. 34. Eiriksdottir G, Sigurdsson A, Jonasson JG, et al. Loss of heterozygosity on chromosome 9 in human breast cancer: association with clinical variables and genetic changes at other chromosome regions. Int J Cancer (Pred Oncol) 1995, 64, 378-382.
35. 35. Schott DR, Chang JN, Deng G, et al. A candidate tumor suppressor gene in human breast cancers. Cancer Res 1994, 54, 1393-1396.
36. 36. Sato T, Tanigami A, Yamakawa K, et al. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 1990, 50, 7184-7189.
37. 37. Muncaster MM, Cohen BL, Phillips RA, Gallic BL. Failure of RB1 to reverse the malignant phenotype of human tumor cell lines. Cancer Res 1992, 52, 654-661.
38. 38. Fuster C, Miro R, Templado C, Barrios L, Egozcue J. Expression of folate-sensitive fragile sites in lymphocyte chromosomes. Hum Genet 1989, 81, 243-246.
39. 39. Maestro R, Piccinin S, Doglioni C, et al. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss. Cancer Res 1996, 56, 1146-1150.
40. 40. Scully R, Chen J, Plug A, et al. Association of BRCA1 and BRCA2 with Rad51 in mitotic and meiotic cells. Cell 1997 88, 265-275.